“Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing”
- Law and Technology
- Health Law
“Understanding Insurance Anti-Discrimination Laws”
“Actavis, the Reverse Payment Fallacy, and the Continuing Need for Regulatory Solutions”
- Constitutional Law
“Responding To Agency Avoidance of OIRA”
“Patent Trolling - Why Bio & Pharmaceuticals Are at Risk”
- Law and Technology
- Health Law
“Towards a New Definition of Public Corporation in Corporate and Securities Laws”
- Corporate and Securities Law
“Long-Term Financial Burden of Breast Cancer: Experiences of a Diverse Cohort of Survivors Identified Through Population-Based Registries”
“ ‘Quack Corporate Governance’ as Traditional Chinese Medicine – The Securities Regulation Cannibalization of China’s Corporate Law and a State Regulator’s Battle Against Party State Political Economic Power”
- International and Comparative Law
“Models of Consent to Return of Incidental Findings in Genomic Research”
- Law and Technology
- Health Law
“Who’s in Charge of Global Finance?”
- International and Comparative Law
- Corporate and Securities Law
“Substantive Habeas”
“Concentrated Ownership and Corporate Control: Wallenberg Sphere and Samsung Group”
- Corporate and Securities Law
“Contemporary Practice of the United States Relating to International Law”
- International and Comparative Law
“The Unrelenting Libertarian Challenge to Public Accommodations Law”
- Civil Rights